Compassionate Use of Cefiderocol in the Treatment of an Intraabdominal Infection Due to Multidrug‐Resistant Pseudomonas aeruginosa : A Case Report-Reference-Cited by-同舟云学术

Compassionate Use of Cefiderocol in the Treatment of an Intraabdominal Infection Due to Multidrug‐Resistant Pseudomonas aeruginosa : A Case Report

Published:2019-10-22 Issue:11 Volume:39 Page:1113-1118
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Stevens Ryan W.¹^ORCID,Clancy Megan²

Affiliation:

1. Mayo Clinic Saint Mary’s Medical Center Rochester Minnesota

2. Providence Alaska Medical Center Anchorage Alaska

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/phar.2334

Reference22 articles.

1. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli

2. In Vitro Antibacterial Properties of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacteria

3. Siderophore cephalosporin cefiderocol utilizes ferric iron transporter systems for antibacterial activity against Pseudomonas aeruginosa;Ito A;Antimicrob Agents Chemother,2016

4. Mechanisms of antibiotic resistance in Pseudomonas aeruginosa;Lambert PA;J R Soc Med,2002

5. Pharmacokinetics, Safety, and Tolerability of Cefiderocol, a Novel Siderophore Cephalosporin for Gram-Negative Bacteria, in Healthy Subjects

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cefiderocol: Clinical application and emergence of resistance;Drug Resistance Updates;2024-01

2. Multidrug-resistant Pseudomonas aeruginosa: A pathogen with challenging clinical management;Enfermedades Infecciosas y Microbiología Clínica;2023-10

3. Multidrug-resistant Pseudomonas aeruginosa: A pathogen with challenging clinical management;Enfermedades infecciosas y microbiologia clinica (English ed.);2023-10

4. Successful use of prolonged cefiderocol monotherapy for the treatment of a complex pleural abscess caused by extensively drug-resistant (XDR) Pseudomonas aeruginosa;JAC-Antimicrobial Resistance;2023-09-04

5. Treatment of critically ill patients with cefiderocol for infections caused by multidrug-resistant pathogens: review of the evidence;Annals of Intensive Care;2023-06-15